Abstract
The pandemic of Coronavirus Disease 2019 (COVID-19) and its variants is rapidly spreading all over the world, generating a high number of infections, deaths and negative impact on socioeconomic system of countries. As vaccines and appropriate drugs for treatment of the COVID-19 can reduce the effectiveness in the presence of variants and/or new viral agents, one of the questions in social studies of medicine is effective public policy responses to reduce the impact of COVID-19 global pandemic and similar infectious diseases on health of people and on economies. This study analyzes public policy responses to the pandemic crisis across Italian regions that were the first areas to experience a rapid increase in confirmed cases and deaths of COVID-19. The analysis of regional strategies, from January to July 2020, reveals differences in public policy responses to delay and reduce the height of epidemic peak and to afford health-care systems more time to expand and respond to this new emergency. Veneto Region in North-East Italy has managed health policy responses with: a) a timely and widespread testing of individuals, b) units of epidemiological investigation for tracing all contacts of infected people in an effective contact tracing system. This public policy response has reduced total deaths and the final size of COVID-19 pandemic on health of people. Other regions have done public interventions without a clear strategy and goals to cope with diffusion of COVID-19 and as a consequence, they have had a higher negative impact on public health. Lesson learned can be important to design an effective public policy that can be generalized in different regional and national systems to prevent and/or reduce future epidemics or pandemics similar to the COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail: mario.coccia{at}cnr.it; igor.benati{at}ircres.cnr.it
1 Vò Euganeo is a town (3,297 inhabitants) not far from Padova (30 km). It became the center of the COVID-19 pandemic in Veneto when two people were found positive on 21 February 2020. The next day, one of them, a 78-year-old man, died, the first COVID-19 death in Italy. On 24th February 2020 an “iron-clad sanitary cordon” was created around the town and a testing program for all of its residents initiated driven by University of Padova.
2 An asymptomatic carrier is an infected individual with a pathogen that does not show symptoms and can transmit it to others, developing symptoms in later stages of the infectious disease.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
